Hubble Therapeutics
Hubble Therapeutics is a biotechnology company focused on developing gene therapy for Leber Congenital Amaurosis Type 16 (LCA16) and Snowflake Vitreoretinal Degeneration (SVD), two rare retinal diseases that lead to severe vision loss. Their mission is to restore vision and improve the quality of life for affected individuals and their families through gene delivery technology targeting the underlying genetic mutations.
Funding Round: Series A
Funding Amount: $7.3M
Date: 25-Mar-2025
Investors: Wisconsin Alumni Research Foundation (WARF)
Markets: Biotechnology, Healthtech, Therapeutics, Health Care, Wellness
HQ: Hanover, New Hampshire, United States
Founded: 2000
Website: https://hubbletx.com/
LinkedIn: https://www.linkedin.com/company/hubble-therapeutics
Crunchbase: https://www.crunchbase.com/organization/hubble-therapeutics
Leave a Comment
Comments
No comments yet.